NYSE Arca · SBIO

ALPS Medical Breakthroughs ETF news

$57.93+0.64%
Close Sep 28, 2026 · split-adjusted
Articles · 30 days1English, de-duplicated
Positive00% of coverage
Neutral1100%
Negative00% of coverage

About ALPS Medical Breakthroughs ETF

Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?
Zacks Investment ResearchSep 8, 6:20 AM ETNeutral

The ETF shows strong recent performance (32.1% YTD, 82.83% 12-month) and reasonable expense ratio (0.5%), but carries high risk (beta 0.74, 30.54% standard deviation) and received a Hold rating. It is presented as a sufficient but not exceptional option compared to lower-cost alternatives.

Also mentions SBIO

Articles that tag SBIO but are mainly about other companies.

None recently.

Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology